Zukowska H, Zwoliński J
Katedry i Kliniki Chorób Płuc, Akademii Medycznej we Wrocławiu.
Pneumonol Alergol Pol. 1996;64(11-12):774-9.
59 patients with non-small cell lung cancer were treated with cisplatin (60 mg/m2) on day 1 and etoposide (60 mg/m2) on days 1-5. The results of the treatment were evaluated after 4th course. Remissions were seen in 27 patients, 17 patients had stabilization and 15-progression. The response rate in stages I and II was 70%, in stage III-40% and in stage IV-23%. In squamous cell carcinoma the response rate was 55%, in large cell carcinoma-25% and in adenocarcinoma-12%.
